SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-16-003499
Filing Date
2016-05-13
Accepted
2016-05-13 07:00:43
Documents
7
Period of Report
2016-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v439726_6k.htm 6-K 17819
2 EXHIBIT 99.1 v439726_ex99-1.htm EX-99.1 124146
3 EXHIBIT 99.2 v439726_ex99-2.htm EX-99.2 243132
4 EXHIBIT 99.3 v439726_ex99-3.htm EX-99.3 95467
5 EXHIBIT 99.4 v439726_ex99-4.htm EX-99.4 10382
6 EXHIBIT 99.5 v439726_ex99-5.htm EX-99.5 10246
7 GRAPHIC tlogo_ex99-3.jpg GRAPHIC 17926
  Complete submission text file 0001279569-16-003499.txt   527141
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Cardiome Pharma Corp (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 161645841
SIC: 2834 Pharmaceutical Preparations